China Archive
15 April 2026
Implementation Opinions of the National Medical Products Administration on Promoting the Integration of Artificial Intelligence into Drug Regulation (2026)
13 April 2026
CMEF 2026 in Shanghai: A global Hub for Medical Innovation and AI-Driven Healthcare
9 April 2026
“Primary evaluation” begins phased implementation and applications of new drugs for registration accepted under initial phase – Hong Kong (2026)
3 April 2026
Anti-Monopoly Law of the People’s Republic of China (2022 Amendment)
2 April 2026
Astrazeneca establishes end to end cell therapy capabilities in Shanghai
1 April 2026
Announcement of NMPA on Further Optimizing the Review and Approval of Clinically Urgently Needed Overseas Marketed Drugs (2026)
26 March 2026
China 15th Five-Year Plan and Its Implications for the Healthcare Industry
23 March 2026
Chinese Commerce Minister Meets Pharma Executives to Promote Foreign Investment
9 March 2026
Cybersecurity Law of the People’s Republic of China (2025 Amendment)
25 February 2026